Umbilical cord mesenchymal stem cell therapy - Shanghai iCELL Biotechnology/Fujian Medical UniversityAlternative Names: UCMSC
Latest Information Update: 27 Nov 2016
At a glance
- Originator Shanghai iCELL Biotechnology
- Class Stem cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Respiratory tract disorders
Most Recent Events
- 03 Nov 2016 Phase-I clinical trials in Respiratory tract disorders (In adults, In the elderly) in China (unspecified route) (NCT02961725)